Terms: = Ovarian cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Diagnosis
8 results:
1. Increased mortality and non-cancer morbidity risk may be associated with early menopause and varies with aetiology: An exploratory population-based study using data-linkage.
Thong EP; Hart RJ; Teede HJ; Vincent AJ; Enticott JC
Maturitas; 2022 Oct; 164():60-66. PubMed ID: 35803198
[TBL] [Abstract] [Full Text] [Related]
2. White Blood Cell BRCA1 Promoter Methylation Status and ovarian cancer Risk.
Lønning PE; Berge EO; Bjørnslett M; Minsaas L; Chrisanthar R; Høberg-Vetti H; Dulary C; Busato F; Bjørneklett S; Eriksen C; Kopperud R; Axcrona U; Davidson B; Bjørge L; Evans G; Howell A; Salvesen HB; Janszky I; Hveem K; Romundstad PR; Vatten LJ; Tost J; Dørum A; Knappskog S
Ann Intern Med; 2018 Mar; 168(5):326-334. PubMed ID: 29335712
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of the potential diagnostic value of serum p53 antibody for cancer: a meta-analysis.
Zhang J; Xu Z; Yu L; Chen M; Li K
PLoS One; 2014; 9(6):e99255. PubMed ID: 24911057
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness of early-initiated treatment for advanced-stage epithelial ovarian cancer patients: a modeling study.
Hoyer T; Bekkers R; Gooszen H; Massuger L; Rovers M; Grutters JP
Int J Gynecol Cancer; 2014 Jan; 24(1):75-84. PubMed ID: 24362714
[TBL] [Abstract] [Full Text] [Related]
5. [State of health of populations residing in geothermal areas of Tuscany].
Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
[TBL] [Abstract] [Full Text] [Related]
6. Diabetes mellitus and cancer risk in a network of case-control studies.
Bosetti C; Rosato V; Polesel J; Levi F; Talamini R; Montella M; Negri E; Tavani A; Zucchetto A; Franceschi S; Corrao G; La Vecchia C
Nutr Cancer; 2012; 64(5):643-51. PubMed ID: 22519904
[TBL] [Abstract] [Full Text] [Related]
7. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study.
Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Kolonel LN; Nomura AM; Terada KY; Carney ME; Sobin LH
Am J Epidemiol; 2003 Oct; 158(7):629-38. PubMed ID: 14507598
[TBL] [Abstract] [Full Text] [Related]
8. Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.
Bolis G; Favalli G; Danese S; Zanaboni F; Mangili G; Scarabelli C; Tateo S; Valsecchi MG; Scarfone G; Richiardi G; Frigerio L; Melpignano M; Villa A; Parazzini F
J Clin Oncol; 1997 May; 15(5):1938-44. PubMed ID: 9164205
[TBL] [Abstract] [Full Text] [Related]
